Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Standard of Care × 30 days × Clear all

Sponsor

Conditions

Neoplasms 5 Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematopoietic and Lymphatic System Neoplasm 3 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Hematologic Neoplasms 2 Carcinoma, Squamous Cell 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Tobacco Use 1 Teratoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Skin Neoplasms 1 Skin Carcinoma 1 Sarcopenia 1 Sarcoglycanopathies 1 Renal Insufficiency, Chronic 1 Progressive Metastatic Castrate Resistant Prostate Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Ovarian Neoplasms 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Radiosurgery 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡